function sa(url,headline_text,source,media_type,cluster,tagline,document_url,harvest_time,access_status,access_registration) 
{
   this.url = url;
   this.headline_text = headline_text;
   this.source = source;
   this.media_type = media_type;
   this.cluster = cluster;
   this.tagline = tagline;
   this.document_url = document_url;
   this.harvest_time = harvest_time;
   this.access_status = access_status;
   this.access_registration = access_registration;
}
article = new Array(
  new sa("http://click.pulse360.com/cgi-bin/clickthrough.cgi?db=context&position=7001&tid=bhniblnobonkbinjbpnmzi&eid=1&id=92091437&creative=209722&query=general%20network%3A(general)&clickid=88033284&tz=US&UNQ=00000125884239681608923000000106051052&value=XOVDQGPA5NUCY&cgroup=&search=hiv%2Faids%20and%20(ata","DON'T Pay for White Teeth","Sponsored Link","text","moreover..."," ","http://click.pulse360.com/cgi-bin/clickthrough.cgi?db=context&position=7001&tid=bhniblnobonkbinjbpnmzi&eid=1&id=92091437&creative=209722&query=general%20network%3A(general)&clickid=88033284&tz=US&UNQ=00000125884239681608923000000106051052&value=XOVDQGPA5NUCY&cgroup=&search=hiv%2Faids%20and%20(ata","10 Nov 2009 06:33:00"," "," "),
  new sa("http://c.moreover.com/click/here.pl?j2323194278","HIV/AIDS - Reports outline HIV/AIDS research from G.A. Lee and colleagues","NewsRX","text","moreover...","","http://www.newsrx.com","10 Nov 2009 06:33:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2317762194","FDA Approves Labeling Update for Bristol-Myers Squibb Company (BMY)'s (JOBS) REYATAZ(R) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients","BioSpace","text","moreover...","","http://www.biospace.com","7 Nov 2009 00:34:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2317620795","FDA Approves Labeling Update For REYATAZ(R) Capsules To Include 96-Week Data For Previously Untreated HIV-1 Infected Adult Patients","Medical News Today","text","moreover...","","http://www.medicalnewstoday.com","6 Nov 2009 23:13:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2316579090","FDA Approves Labeling Update for Bristol-Myers Squibb Company (BMY)'s REYATAZ(R) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients","BioSpace","text","moreover...","","http://www.biospace.com","6 Nov 2009 14:53:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2315659259","FDA Approves Labeling Update for REYATAZ (atazanavir sulfate) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients","Pharmacy Choice","text","moreover...","","http://www.pharmacychoice.com","6 Nov 2009 06:47:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2315325736","FDA Approves Labeling Update for REYATAZ® (atazanavir sulfate) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients","Freshnews.com","text","moreover...","","http://www.freshnews.com","6 Nov 2009 03:04:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2315214478","FDA Approves Labeling Update for REYATAZ® (atazanavir sulfate) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients","Business Wire UK","text","moreover...","","http://businesswire.com","6 Nov 2009 01:58:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2315130398","FDA Approves Labeling Update for REYATAZ(R) (atazanavir sulfate) Capsules to Include 96-Week...","Forbes.com","text","moreover...","","http://forbes.com","6 Nov 2009 01:13:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2315045282","FDA Approves Labeling Update for REYATAZ (atazanavir sulfate) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients","Yahoo! Canada","text","moreover...","","http://ca.us.biz.yahoo.com","6 Nov 2009 00:29:00","","")
);